XML 30 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
2 Months Ended 4 Months Ended 5 Months Ended 9 Months Ended 12 Months Ended
May 31, 2021
Sep. 30, 2020
Sep. 30, 2021
Dec. 31, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Dec. 31, 2019
Cash flows from Operating Activities:                
Net loss         $ (98,465,000) $ (23,414,000) $ (137,336,000) $ (18,302,000)
Adjustments to reconcile net loss to net cash used in operating activities:                
Accrued expenses and other liabilities         1,424,000 18,000 128,000 1,009,000
Depreciation and amortization         1,069,000 48,000 235,000 88,000
Equity-based compensation         1,033,000 53,000 7,363,000 70,000
Change in fair value of warrant liability         61,184,000 (554,000) 97,604,000
Change in fair value of derivative             (1,918,000)
Gain on extinguishment of debt             (18,000)
Asset retirement obligation accretion             71,000 27,000
Fixed asset write-off         66,000 259,000
Changes in operating assets and liabilities:                
Deferred revenue             (14,000) 6,000
Issuance of warrants for rent expense         5,504,000    
Asset retirement obligation accretion         56,000 53,000    
Amortization of debt issuance costs and discount         671,000 473,000 748,000 1,485,000
Accrued payment in kind (PIK) interest on debt         4,231,000 2,438,000 3,554,000 1,331,000
Other current assets         (4,074,000) 1,937,000    
Other assets         (3,276,000) (40,000)    
Prepaid expenses             (860,000) 187,000
Accounts payable         1,148,000 153,000 (157,000) 520,000
Net cash used in operating activities         (29,429,000) (18,835,000) (28,405,000) (15,515,000)
Cash flows from Investing Activities:                
Capitalization of costs and purchases of network assets, property, and equipment         (857,000) (5,701,000) (6,419,000) (59,000)
Purchase of internal use software         (197,000) (21,000) (759,000)
Cash used in investing activities         (1,054,000) (5,722,000) (7,178,000) (59,000)
Cash flows from Financing Activities:                
Proceeds from convertible notes, net             7,022,000
Proceeds from senior secured loan         18,467,000 35,215,000 40,307,000 23,635,000
Senior secured loan issuance costs         (5,378,000) (5,539,000) (2,857,000)
Convertible note repayment             (3,800,000)
Proceeds from exercise of Class A unit options             3,000 4,000
Proceeds from issuance of Class A Common Units         2,000    
Net cash provided by financing activities         18,469,000 29,837,000 34,771,000 24,004,000
Effect of exchange rates on cash and cash equivalents and restricted cash         (14,000) (1,000) (1,000)
Net (decrease) increase in cash and cash equivalents and restricted cash         (12,028,000) 5,279,000 (812,000) 8,429,000
Cash, cash equivalents and restricted cash at beginning of period         13,669,000 14,481,000 14,481,000 6,052,000
Cash, cash equivalents and restricted cash at end of period   $ 19,760,000 $ 1,641,000 $ 13,669,000 1,641,000 19,760,000 13,669,000 14,481,000
Supplemental cash flow information                
Capital expenditures included in Accounts payable         112,000 128,000    
Settlement of notes payable for Class D preferred shares             (18,544,000)
Financing costs accrued but not paid             (5,378,000)
Issuance of Warrants         5,504,000 (222,000) $ (3,531,000)
Spartacus Acquisition Shelf Corp. [Member]                
Cash flows from Operating Activities:                
Net loss $ (2,792)   (293,081)          
Adjustments to reconcile net loss to net cash used in operating activities:                
Due to affiliate     293,081          
Accrued expenses and other liabilities 2,792              
Accretion of interest on cash and marketable securities held in Trust Account            
Change in fair value of warrant liability            
Changes in operating assets and liabilities:                
Net cash used in operating activities            
Cash flows from Financing Activities:                
Net (decrease) increase in cash and cash equivalents and restricted cash            
Cash, cash equivalents and restricted cash at beginning of period            
Cash, cash equivalents and restricted cash at end of period          
Spartacus Acquisition Corp [Member]                
Cash flows from Operating Activities:                
Net loss   (1,873)   (3,733,764) (12,387,895)      
Adjustments to reconcile net loss to net cash used in operating activities:                
Accretion of interest on cash and marketable securities held in Trust Account     (28,982) (47,296)      
Change in fair value of warrant liability     2,975,000 8,900,000      
Changes in operating assets and liabilities:                
Transaction costs allocated to warrant liability       604,606        
Due from Sponsor and related parties       (6,090)      
Prepaid expenses     (165,091) (104,717)      
Due to related party   75     65      
Accounts payable     96,670 2,074,944      
Net cash used in operating activities   (1,798)   (251,561) (1,570,989)      
Cash flows from Investing Activities:                
Purchase of marketable securities       (406,042,000)      
Maturity of marketable securities       406,042,000      
Purchase of investment held in Trust Account       (202,995,370)        
Principal deposited in Trust Account       (4,630)        
Cash used in investing activities     (203,000,000)      
Cash flows from Financing Activities:                
Proceeds from issuance of promissory note to related party   188,500   191,046 600,000      
Repayment of Promissory Note to Sponsor       (191,046)        
Payment of offering costs       (516,309)        
Proceeds from initial public offering, net of underwriting discounts paid       196,000,000        
Proceeds from Private Placement Warrants       8,750,000        
Proceeds from issuance of founder shares   25,000   25,000      
Payment of deferred offering costs   (183,443)          
Net cash provided by financing activities   30,057   204,258,691 600,000      
Net (decrease) increase in cash and cash equivalents and restricted cash   28,259   1,007,130 (970,989)      
Cash, cash equivalents and restricted cash at beginning of period     1,007,130      
Cash, cash equivalents and restricted cash at end of period   28,259 $ 36,141 1,007,130 36,141 $ 28,259 $ 1,007,130  
Supplemental cash flow information                
Increase in accounts payable and accrued expenses for deferred offering costs       70,000      
Accrued deferred underwriting fee       7,000,000        
Initial classification of warrant liability       20,037,500        
Initial value of Class A common stock subject to possible redemption       172,248,666        
Change in value of Class A common stock subject to possible redemption     $ 3,156,634 21,569      
Supplemental disclosure of cash flow information:                
Cash taxes paid       47,213      
Transfer of cash from trust for payment of Delaware state franchise tax       $ 68,864